Considering that the androgen-receptor–paxillin complex occupies promoters of androgen-receptor-responsive genes, such as PSA (also known as KLK3) or NKX3-1 in prostate cancer cell line (Sen et al., 2012), it is worth exploring whether paxillin is employed here in a similar way. This evidence concerns the gene AR and prostate carcinoma.